These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Intravenous immunoglobulins and autoimmune thrombopenic purpura]. Godeau B; Bierling P Rev Med Interne; 1999; 20 Suppl 4():440s-443s. PubMed ID: 10522320 [TBL] [Abstract][Full Text] [Related]
47. Clinical uses of intravenous immunoglobulin in pregnancy. Clark AL; Gall SA Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):241-53. PubMed ID: 9024121 [TBL] [Abstract][Full Text] [Related]
48. [The indications for intravenous immunoglobulins in pediatric practice]. Popescu V; Bleahu D Pediatrie (Bucur); 1992; 41(1):37-45. PubMed ID: 1322724 [TBL] [Abstract][Full Text] [Related]
49. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy. Yoshida S; Sakurai Y; Takeda T; Fukuda K J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975 [No Abstract] [Full Text] [Related]
50. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [TBL] [Abstract][Full Text] [Related]
51. Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. Pacetti P; Garau D; Caramatti C; Mangoni L; Zamboni V; Canova N; Rizzoli V Curr Med Res Opin; 1997; 13(9):517-27. PubMed ID: 9169254 [TBL] [Abstract][Full Text] [Related]
52. Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura--a case report and literature review. Crouch ED; Watson LE Angiology; 2002; 53(1):113-7. PubMed ID: 11863304 [TBL] [Abstract][Full Text] [Related]
53. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease. Khan S; Doré PC; Sewell WA Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907 [No Abstract] [Full Text] [Related]
54. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997 [TBL] [Abstract][Full Text] [Related]
55. Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP). Paolini R; Fabris F; Cella G Am J Hematol; 2000 Oct; 65(2):177-8. PubMed ID: 10996840 [No Abstract] [Full Text] [Related]
56. Anti-D testing in intravenous immunoglobulins: shouldn't it be considered. Pisani G; Wirz M; Gentili G Vox Sang; 1996; 71(2):132. PubMed ID: 8873429 [No Abstract] [Full Text] [Related]
57. [Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin]. Mori M Nihon Rinsho; 2008 Feb; 66(2):349-54. PubMed ID: 18260334 [TBL] [Abstract][Full Text] [Related]
58. Intravenous immunoglobulins: clinical experience and viral safety. Ballow M J Am Pharm Assoc (Wash); 2002; 42(3):449-58; quiz 458-9. PubMed ID: 12030632 [TBL] [Abstract][Full Text] [Related]
59. The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. Ruivard M; Caulier MT; Vantelon JM; Tournilhac O; Schaeffer A; Godeau B; Bierling P Br J Haematol; 1999 Jun; 105(4):1130-2. PubMed ID: 10554833 [TBL] [Abstract][Full Text] [Related]